Liver metastases as predictors of outcome in renal cell carcinoma (RCC) patients (pts) treated with first-line sunitinib (SU) and sorafenib (SO).
Paolo Grassi
No relevant relationships to disclose
Elena Verzoni
No relevant relationships to disclose
Luca Porcu
No relevant relationships to disclose
Isabella Testa
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Enrico Garanzini
No relevant relationships to disclose
Roberto Salvioni
No relevant relationships to disclose
Filippo G. De Braud
No relevant relationships to disclose
Giuseppe Procopio
Employment or Leadership Position - Astellas Pharma; Bayer; GlaxoSmithKline
Consultant or Advisory Role - Janssen; Novartis; Pfizer; Sanofi